London, UK (PRWEB UK) 23 June 2013
According to a study carried out on May 21st at Quinnipiac University in Hamden, thousands of people suffering with Chronic Obstructive Pulmonary Disease, or COPD, could reduce disease flare-ups with a course of the antibiotic azithromycin. Researchers have found that the antibiotic could help to cut down on the number of GP visits, as well as helping to boost the quality of life for those with the condition. The study involved looking at how patients on a 12-month course of the drug fared in comparison to those taking a placebo. (http://www.healthfinder.gov/News/Article/676442/long-term-use-of-antibiotic-may-help-those-with-copd)
In order to determine how effective the drug was, researchers compared the results against data from a previous study carried out by the COPD Clinical Research Network. Dr. Fernando Martinez, lead author of the study, explained "COPD patients who have been hospitalised for a respiratory event are at particularly high risk for re-hospitalisation. We wanted to examine whether chronic azithromycin therapy might provide a benefit in these patients” (http://www.healthfinder.gov/News/Article/676442/long-term-use-of-antibiotic-may-help-those-with-copd)
With this in mind, Yourwellness Magazine took a closer look at COPD and the various health risks associated with it. This progressive disease is often associated with smoking and involves bronchitis and emphysema, making breathing difficult. According to Yourwellness Magazine, studies have found that there is a higher mortality risk in patients with a moderate to severe case of COPD. However, they state that this could be “good news for COPD wellness, as the discovery could mean that if you have COPD, and are suitable for preventive antibiotic treatment; your doctor may be able to identify you more quickly” (http://www.yourwellness.com/2013/03/does-bronchiectasis-threaten-the-lives-of-copd-patients/).
Yourwellness Magazine explained that in a study, carried out by the University La Fe Hospital in Valencia, researchers noted that bronchiectasis can be diagnosed with a high-resolution CT scan and effective treatments can be provided - if the prognostic value of bronchiectasis in COPD patients is confirmed, this could potentially reduce the mortality risk in these patients. They concluded that early diagnosis and treatment could break the pathogenic circle of infection and inflammation which leads to the development of bronchiectasis.